Skip to main content
European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary

Stimuli Responsive Materials for the Rapid Detection and Treatment of Healthcare Associated Infections

Descripción del proyecto

Materiales tratanósticos avanzados para diagnosticar y tratar las heridas infectadas

Las heridas difíciles de curar son un desafío tanto para los pacientes como para los médicos. El objetivo del tratamiento es proteger de las infecciones bacterianas y acelerar la curación. Por desgracia, estas infecciones no son poco comunes. Los materiales de recubrimiento actuales se basan en la difusión lenta y pasiva de antimicrobianos. Esto significa que es posible que no sean lo suficientemente concentrados para eliminar la infección. Para abordar este desafío, el proyecto STIMULUS, financiado con fondos europeos, creará materiales que indiquen rápidamente la presencia de una infección (diagnóstico) y provoquen la liberación de antimicrobianos para tratarla (tratamiento). El proyecto integrará materiales sensibles en prototipos de apósitos. Además, capacitará a investigadores noveles para liderar la investigación sobre productos sanitarios tratanósticos.

Objetivo

Healthcare Associated Infections (HAIs) are bacterial infections obtained as a result of clinical treatment e.g. following medical intervention. HAIs are a problem of tremendous proportion as more than 4 million EC citizens get infected annually. The ECDC estimates 147,000 HAI-related deaths in Europe each year, a large part stemming from wound infections. These alarming facts motivate the urgent need to develop novel medical devices, in particular wound dressings, which rapidly signal and prevent or eradicate invasive bacterial colonization following a stimulus. Current antimicrobial coatings rely on slow, passive diffusion of antimicrobials, hence the antimicrobial may not be sufficiently concentrated to eradicate the infection; such low concentration zones promote evolution of resistance. To tackle these challenges in healthcare in light of an increasingly aging population and unprecedented antibiotic resistance levels, there is an urgent need for dedicated research leaders in industry and academia. These scientists of the future still will need primary training in, e.g. chemistry or microbiology, but they will have to operate at the interface between disciplines. Future materials chemists will need to perform microbiology experiments and to appreciate the engineering required to translate a lab invention to a production prototype. They have to understand the societal, business and regulatory environment around new medical device development. The research focus of STIMULUS is on wound infections. The objectives are: 1) Diagnostic: To create materials that clearly and rapidly signal when infection is present; 2) Therapeutic: triggered release of antimicrobials to treat the infection; 3) Translational and theranostic: integration of responsive materials into prototype wound dressings. Integrated with this research, we will create a lasting and comprehensive training programme for ESRs, making them suitable for leading research on theranostic medical devices.

Coordinador

UNIVERSITAET FUER BODENKULTUR WIEN
Aportación neta de la UEn
€ 528 414,48
Dirección
GREGOR MENDEL STRASSE 33
1180 Wien
Austria

Ver en el mapa

Región
Ostösterreich Wien Wien
Tipo de actividad
Higher or Secondary Education Establishments
Enlaces
Coste total
€ 528 414,48

Participantes (8)